(Q38426149)

3 September 2017

0 references

Chemotherapy and radiotherapy in nasopharyngeal carcinoma: an update of the MAC-NPC meta-analysis (English)

1 reference

3 September 2017

0 references

1 reference

1 reference

19

George Fountzilas

1 reference

ORCID Public Data File 2021

3 September 2017

1 reference

author name string

Pierre Blanchard

1

1 reference

3 September 2017

Anne Lee

2

1 reference

3 September 2017

Sophie Marguet

3

1 reference

3 September 2017

Julie Leclercq

4

1 reference

3 September 2017

Wai Tong Ng

5

1 reference

3 September 2017

Jun Ma

6

1 reference

3 September 2017

Anthony T C Chan

7

1 reference

3 September 2017

Pei-Yu Huang

8

1 reference

3 September 2017

Ellen Benhamou

9

1 reference

3 September 2017

Guopei Zhu

10

1 reference

3 September 2017

Daniel T T Chua

11

1 reference

3 September 2017

Yong Chen

12

1 reference

3 September 2017

Hai-Qiang Mai

13

1 reference

3 September 2017

Dora L W Kwong

14

1 reference

3 September 2017

Shie Lee Cheah

15

1 reference

3 September 2017

James Moon

16

1 reference

3 September 2017

Yuk Tung

17

1 reference

3 September 2017

Kwan-Hwa Chi

18

1 reference

3 September 2017

Li Zhang

20

1 reference

3 September 2017

Edwin Pun Hui

21

1 reference

3 September 2017

Tai-Xiang Lu

22

1 reference

3 September 2017

Jean Bourhis

23

1 reference

3 September 2017

Jean Pierre Pignon

24

1 reference

3 September 2017

MAC-NPC Collaborative Group

25

1 reference

3 September 2017

6 May 2015

1 reference

Lancet Oncology Commission

3 September 2017

1 reference

3 September 2017

16

1 reference

3 September 2017

6

1 reference

3 September 2017

645-655

1 reference

Current management of nasopharyngeal cancer.

3 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2970126-9

7 January 2021

Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: phase III randomized Intergroup study 0099

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2970126-9

7 January 2021

Chemotherapy in locally advanced nasopharyngeal carcinoma: an individual patient data meta-analysis of eight randomized trials and 1753 patients.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2970126-9

7 January 2021

Practical methodology of meta-analyses (overviews) using updated individual patient data. Cochrane Working Group

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2970126-9

7 January 2021

A note on quantifying follow-up in studies of failure time

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2970126-9

7 January 2021

Beta blockade during and after myocardial infarction: an overview of the randomized trials

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2970126-9

7 January 2021

Meta-analysis of the literature or of individual patient data: is there a difference?

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2970126-9

7 January 2021

Quantifying heterogeneity in a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2970126-9

7 January 2021

A critical review of methods for the assessment of patient-level interactions in individual participant data meta-analysis of randomized trials, and guidance for practitioners.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2970126-9

7 January 2021

A prospective randomized study of chemotherapy adjunctive to definitive radiotherapy in advanced nasopharyngeal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2970126-9

7 January 2021

Preliminary report of the Asian-Oceanian Clinical Oncology Association randomized trial comparing cisplatin and epirubicin followed by radiotherapy versus radiotherapy alone in the treatment of patients with locoregionally advanced nasopharyngeal ca

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2970126-9

7 January 2021

Preliminary results of a randomized trial comparing neoadjuvant chemotherapy (cisplatin, epirubicin, bleomycin) plus radiotherapy vs. radiotherapy alone in stage IV(> or = N2, M0) undifferentiated nasopharyngeal carcinoma: a positive effect on progr

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2970126-9

7 January 2021

A prospective, randomized trial comparing neoadjuvant chemotherapy with radiotherapy alone in patients with advanced nasopharyngeal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2970126-9

7 January 2021

A phase III study of adjuvant chemotherapy in advanced nasopharyngeal carcinoma patients

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2970126-9

7 January 2021

Overall Survival After Concurrent Cisplatin-Radiotherapy Compared With Radiotherapy Alone in Locoregionally Advanced Nasopharyngeal Carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2970126-9

7 January 2021

Concurrent and adjuvant chemotherapy for nasopharyngeal carcinoma: a factorial study

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2970126-9

7 January 2021

Concurrent chemoradiotherapy plus adjuvant chemotherapy versus concurrent chemoradiotherapy alone in patients with locoregionally advanced nasopharyngeal carcinoma: a phase 3 multicentre randomised controlled trial.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2970126-9

7 January 2021

Randomized trial of radiotherapy versus concurrent chemoradiotherapy followed by adjuvant chemotherapy in patients with American Joint Committee on Cancer/International Union against cancer stage III and IV nasopharyngeal cancer of the endemic varie

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2970126-9

7 January 2021

Randomized trial of radiotherapy plus concurrent-adjuvant chemotherapy vs radiotherapy alone for regionally advanced nasopharyngeal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2970126-9

7 January 2021

A randomized trial on addition of concurrent-adjuvant chemotherapy and/or accelerated fractionation for locally-advanced nasopharyngeal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2970126-9

7 January 2021

Randomized phase II trial of concurrent cisplatin-radiotherapy with or without neoadjuvant docetaxel and cisplatin in advanced nasopharyngeal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2970126-9

7 January 2021

Induction chemotherapy followed by concomitant radiotherapy and weekly cisplatin versus the same concomitant chemoradiotherapy in patients with nasopharyngeal carcinoma: a randomized phase II study conducted by the Hellenic Cooperative Oncology Grou

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2970126-9

7 January 2021

Long-term follow-up of a phase III study comparing radiotherapy with or without weekly oxaliplatin for locoregionally advanced nasopharyngeal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2970126-9

7 January 2021

A randomized trial of induction chemotherapy plus concurrent chemoradiotherapy versus induction chemotherapy plus radiotherapy for locoregionally advanced nasopharyngeal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2970126-9

7 January 2021

Concurrent chemoradiotherapy vs radiotherapy alone in stage II nasopharyngeal carcinoma: phase III randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2970126-9

7 January 2021

Progress report of a randomized trial comparing long-term survival and late toxicity of concurrent chemoradiotherapy with adjuvant chemotherapy versus radiotherapy alone in patients with stage III to IVB nasopharyngeal carcinoma from endemic regions

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2970126-9

7 January 2021

Preliminary results of a prospective randomized trial comparing concurrent chemoradiotherapy plus adjuvant chemotherapy with radiotherapy alone in patients with locoregionally advanced nasopharyngeal carcinoma in endemic regions of china

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2970126-9

7 January 2021

Factors contributing to the efficacy of concurrent–adjuvant chemotherapy for locoregionally advanced nasopharyngeal carcinoma: Combined analyses of NPC-9901 and NPC-9902 Trials

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2970126-9

7 January 2021

Preliminary results of trial NPC-0501 evaluating the therapeutic gain by changing from concurrent-adjuvant to induction-concurrent chemoradiotherapy, changing from fluorouracil to capecitabine, and changing from conventional to accelerated radiother

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2970126-9

7 January 2021

Taxane-cisplatin-fluorouracil as induction chemotherapy in locally advanced head and neck cancers: an individual patient data meta-analysis of the meta-analysis of chemotherapy in head and neck cancer group.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2970126-9

7 January 2021

10.1016/S1470-2045(15)70126-9

Identifiers

DOI

1 reference

3 September 2017

1 reference